The spectrum of perinatal group B streptococcal disease

Vaccine

Volumn 31, Issue S4, 2013, Pages

  Baker, Carol J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Group B Streptococcus; Maternal immunization; Meningitis; Neonates; Pregnancy; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; GLYCOCONJUGATE; GROUP B STREPTOCOCCUS VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; AMNIONITIS; ANTIBIOTIC PROPHYLAXIS; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INNATE IMMUNITY; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENESIS; PERINATAL CARE; PERINATAL MORBIDITY; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS AGALACTIAE;

CAPSULAR POLYSACCHARIDE; CDC; CENTERS FOR DISEASE CONTROL AND PREVENTION; CPS; GBS; GROUP B STREPTOCOCCUS; IAI; IAP; IG; IMMUNOGLOBULIN; INTRA-AMNIOTIC INFECTION; INTRAPARTUM ANTIBIOTIC PROPHYLAXIS; MATERNAL IMMUNIZATION; MENINGITIS; NEONATES; PREGNANCY; PRETERM LABOR; PROLONGED RUPTURE OF MEMBRANES; PROM; PTL; TETANUS TOXOID; TT; UNITED STATES; US; VACCINE;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; HUMANS; IMMUNIZATION; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE;

EID: 84882942208     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.030     Document Type: Review

References (16)

1. Lancefield R.C. A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med 1933, 57:571-595.
2. Lancefield R.C., Hare R. The serological differentiation of pathogenic and non-pathogenic strains of hemolytic streptococci from parturient women. J Exp Med 1935, 61:335-349.
3. Fry R.M. Fatal infections by haemolytic Streptococcus group B. Lancet 1938, 1:199-201.
4. Edwards M.S., Nizet V., Baker C.J. Group B streptococcal infections. Infectious diseases of the fetus and newborn infant 2011, 419-469. Elsevier Saunders, Philadelphia. 7th ed. J.S. Remington, J.O. Klein, C.B. Wilson, V. Nizet, Y.A. Maldonado (Eds.).
5. Baker C.J., Barrett F.F., Gordon R.C., Yow M.D. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr 1973, 82:724-729.
6. Baker C.J., Barrett F.F. Group B streptococcal infections in infants: the importance of the various serotypes. JAMA 1974, 230:1158-1160.
7. Baker C.J., Kasper D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal infection with group B Streptococcus. N Engl J Med 1976, 294:753-756.
8. Baker C.J., Kasper D.L., Tager I.B., Paredes A., Alpert S., McCormack W.M., et al. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest 1977, 59:810-818.
9. Baker C.J., Kasper D.L., Davis C.E. Immunochemical characterization of native type III polysaccharide of group B Streptococcus. J Exp Med 1976, 143:258-270.
10. Sørensen U.B.S., Poulsen K., Ghezzo C., Margarit I., Kilian M. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. mBio 2010, 1:e00178-e210.
11. Margarit I., Rinaudo C.D., Galeotti C.L., Maione D., Ghezzo C., Buttazzoni E., et al. Preventing bacterial infections with pilus-based vaccines: the group B Streptococcus paradigm. J Infect Dis 2009, 199:108-115.
12. Phares C.R., Lynfield R., Farley M.M., Mohle-Boetani J., Harrison L.H., Petit S., et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299:2056-2065.
13. Thigpen M.C., Whitney C.G., Messonnier N.E., Zell E.R., Lynfield R., Hadler J.L., et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011, 364:2016-2025.
14. Libster R., Edwards K.M., Levent F., Edwards M.S., Rench M.A., Castagnini L.A., et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012, 130:e8-e15.
15. Dagnew A.F., Cunnington M.C., Dube Q., Edwards M.S., French N., Madhi S.A., et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis 2012, 55:91-102.
16. Baker C.J. Immunization to prevent group B streptococcal disease: victories and vexations. J Infect Dis 1990, 161:917-921.